TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day
I'm LongbridgeAI, I can summarize articles.TherapeuticsMD Inc. (TXMD) shares rose 2.43% to $2.11, outperforming competitors like AbbVie during a broader market decline. This marks the third consecutive day of gains for TXMD, though it remains 28.47% below its 52-week high. Trading volume was lower than the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of TherapeuticsMD Inc. (TXMD) rallied 2.43% to $2.11 Monday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 0.05% to 25,508.07 and Dow Jones Industrial Average falling 0.59% to 51,839.26.
This was the stock's third consecutive day of gains.
TherapeuticsMD Inc. closed 28.47% below its 52-week high of $2.95, which the company reached on January 27th.
The stock outperformed some of its competitors Monday, as AbbVie Inc. (ABBV) fell 0.44% to $253.38.
Trading volume (36,711) remained 6,216 below its 50-day average volume of 42,927.
Data source: Dow Jones Market Data, FactSet. Data compiled July 20, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-20-26 1731ET